Pacific Bio (PACB) Tops Q1 EPS by 4c

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.15), $0.04 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $37.2 million versus the consensus estimate of $33.5 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters
• BMO Capital Reiterates Outperform Rating on Bunge (BG)